FDA Logo links to FDA home page
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On January 31, 2006
Table of Contents
Docket # Title
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1999N-4282 Biotechnology in the Year 2000 and Beyond; Public Meetings
2000P-1211 Establish Mandatory Pre-Market Safety Testing for GE Foods
2004D-0555 Class II Special Controls Draft Guidance; Labeling for Male Condoms Made of Natural Rubber Latex
2004N-0556 Obstetrical and Gynecological Devices; Designation of Special Control for Condom and Condom with Spermicidal Lubricant
2005D-0481 Guidance for Industry, Lead in Candy Likely To Be Consumed Frequently by Small Children: Recommended Maximum Level and Enforcement Policy, Availability; and draft supporting document, Supporting Do
2005P-0267 Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 17197 Enzymatic Therapy Vol #: 157
LET 17198 Enzymatic Therapy Vol #: 157
LET 17199 Enzymatic Therapy Vol #: 157
LET 17200 Enzymatic Therapy Vol #: 157
LET 17201 Enzymatic Therapy Vol #: 157
LET 17202 Enzymatic Therapy Vol #: 157
LET 17203 Enzymatic Therapy Vol #: 157
LET 17204 Enzymatic Therapy Vol #: 157
LET 17205 Enzymatic Therapy Vol #: 157
LET 17206 Enzymatic Therapy Vol #: 157
LET 17207 Enzymatic Therapy Vol #: 157
LET 17208 Enzymatic Therapy Vol #: 157
LET 17209 Enzymatic Therapy Vol #: 157
LET 17210 Enzymatic Therapy Vol #: 157
LET 17211 Enzymatic Therapy Vol #: 157
LET 17212 Enzymatic Therapy Vol #: 157
LET 17213 Enzymatic Therapy Vol #: 157
LET 17214 Enzymatic Therapy Vol #: 157
LET 17215 Enzymatic Therapy Vol #: 157
LET 17216 Enzymatic Therapy Vol #: 157
LET 17217 Enzymatic Therapy Vol #: 157
LET 17218 Enzymatic Therapy Vol #: 157
LET 17219 Enzymatic Therapy Vol #: 158
LET 17220 Enzymatic Therapy Vol #: 158
LET 17221 Enzymatic Therapy Vol #: 158
LET 17222 Enzymatic Therapy Vol #: 158
LET 17223 Enzymatic Therapy Vol #: 158
LET 17224 Enzymatic Therapy Vol #: 158
LET 17225 Enzymatic Therapy Vol #: 158
LET 17226 Enzymatic Therapy Vol #: 158
LET 17227 Enzymatic Therapy Vol #: 158
LET 17228 Enzymatic Therapy Vol #: 158
LET 17229 Enzymatic Therapy Vol #: 158
LET 17230 Enzymatic Therapy Vol #: 158
LET 17231 Enzymatic Therapy Vol #: 158
LET 17232 Iovate Health Sciences U.S.A. Inc. Vol #: 158
LET 17233 Iovate Health Sciences U.S.A. Inc. Vol #: 158
LET 17234 Beulah Land Corporation Vol #: 158
LET 17235 Beulah Land Corporation Vol #: 158
LET 17236 Beulah Land Corporation Vol #: 158
LET 17237 Beulah Land Corporation Vol #: 158
LET 17238 Beulah Land Corporation Vol #: 158
LET 17239 Beulah Land Corporation Vol #: 158
LET 17240 Beulah Land Corporation Vol #: 158
LET 17241 Beulah Land Corporation Vol #: 158
LET 17242 Beulah Land Corporation Vol #: 158
LET 17243 Beulah Land Corporation Vol #: 158
LET 17244 Beulah Land Corporation Vol #: 158
LET 17245 Beulah Land Corporation Vol #: 158
1999N-4282 Biotechnology in the Year 2000 and Beyond; Public Meetings
C 18247 M. Yahres Vol #: 516
2000P-1211 Establish Mandatory Pre-Market Safety Testing for GE Foods
C 12841 M. Yahres Vol #: 806
2004D-0555 Class II Special Controls Draft Guidance; Labeling for Male Condoms Made of Natural Rubber Latex
C 4 American Society for Reproductive Medicine (ASRM) Vol #: 1
2004N-0556 Obstetrical and Gynecological Devices; Designation of Special Control for Condom and Condom with Spermicidal Lubricant
C 1 American Society for Reproductive Medicine (ASRM) Vol #: 1
2005D-0481 Guidance for Industry, Lead in Candy Likely To Be Consumed Frequently by Small Children: Recommended Maximum Level and Enforcement Policy, Availability; and draft supporting document, Supporting Do
C 1 B. Wagner, JD, MPH, REHS Vol #: 1
2005P-0267 Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
C 83 Medial Center of Southeastern Oklahoma Vol #: 20
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
C 483 R. Mathis Vol #: 6
C 484 J. McAndrew Vol #: 6
C 485 C. Kershaer Vol #: 6
C 486 M. Levi Vol #: 6
C 487 C. Barnes Vol #: 6
C 488 D. Schultz Vol #: 6

Page created on February 13, 2006 RSC

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management